首页 / / Development History
2023
Reading frequency:234  Updated on:2023-07-24
★ Completion of Series A Financing, Reinforcement of R&D Investment;
★ H1 2023: Initiation of New Third Board Listing, Laying the Foundation for Beijing Stock Exchange IPO;
★ Further Optimization of Management Structure, Strengthening Management and Technical Training, Consolidating Robust Operational Foundation;
★ Consolidation of New Teams, Strengthening Technical Platforms; Maturation of CRO, CMO, and CDMO Modes.
PREV: 2022
NEXT: Taiji Group
Copyright 2024 Nanjing Chiheal Bio Medicine Technology Co..Ltd All rights reserved.